Hao Liao

466 total citations
23 papers, 273 citations indexed

About

Hao Liao is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Hao Liao has authored 23 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Epidemiology, 20 papers in Hepatology and 1 paper in Infectious Diseases. Recurrent topics in Hao Liao's work include Hepatitis B Virus Studies (21 papers), Hepatitis C virus research (20 papers) and Liver Disease Diagnosis and Treatment (18 papers). Hao Liao is often cited by papers focused on Hepatitis B Virus Studies (21 papers), Hepatitis C virus research (20 papers) and Liver Disease Diagnosis and Treatment (18 papers). Hao Liao collaborates with scholars based in China, United States and Netherlands. Hao Liao's co-authors include Dongping Xu, Yan Liu, Fengmin Lu, Jun Wang, Lanlan Si, Rongjuan Chen, Xiangmei Chen, Lujie Liu, Xiaodong Li and Xiaodong Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, World Journal of Gastroenterology and Clinica Chimica Acta.

In The Last Decade

Hao Liao

23 papers receiving 272 citations

Peers

Hao Liao
Vedran Pavlovic United Kingdom
Noorann Sheikh United Kingdom
Vincent Ngai Hong Kong
Soree Park South Korea
Jeffrey Gersch United States
Vedran Pavlovic United Kingdom
Hao Liao
Citations per year, relative to Hao Liao Hao Liao (= 1×) peers Vedran Pavlovic

Countries citing papers authored by Hao Liao

Since Specialization
Citations

This map shows the geographic impact of Hao Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Liao more than expected).

Fields of papers citing papers by Hao Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Liao. The network helps show where Hao Liao may publish in the future.

Co-authorship network of co-authors of Hao Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Hao Liao. A scholar is included among the top collaborators of Hao Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao Liao. Hao Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liao, Hao, et al.. (2024). Valuable metals recovery from spent ternary lithium-ion battery: A review. International Journal of Minerals Metallurgy and Materials. 31(12). 2556–2581. 13 indexed citations
2.
Gu, Zhiqiang, Chunyan Sun, Zimin Chen, et al.. (2023). A novel hepatitis B virus capsid assembly modulator QL-007 inhibits HBV replication and infection through altering capsid assembly. Antiviral Research. 218. 105715–105715. 3 indexed citations
3.
Zhao, Jing, Dan‐Dan Bian, Hao Liao, et al.. (2023). Serum HBsAg and HBcrAg is associated with inflammation in HBeAg-positive chronic hepatitis B patients. Frontiers in Cellular and Infection Microbiology. 13. 1083912–1083912. 8 indexed citations
4.
Liao, Hao, He Zhang, Xiaoyong Li, et al.. (2023). Nucleos(t)ide analogues altered quasispecies composition of hepatitis B virus (HBV)‐resistant mutations in serum HBV DNA and serum HBV RNA. Journal of Medical Virology. 95(3). 2 indexed citations
5.
Wang, Yang, Hao Liao, Yanna Liu, et al.. (2022). Serum HBV RNA predicts HBeAg clearance and seroconversion in patients with chronic hepatitis B treated with nucleos(t)ide analogues. Journal of Viral Hepatitis. 29(6). 420–431. 11 indexed citations
6.
Liao, Hao, Wei Zheng, Jun Zou, et al.. (2022). Characteristics of HBV Novel Serum Markers across Distinct Phases in Treatment-Naïve Chronic HBV-Infected Patients. Disease Markers. 2022. 1–13. 7 indexed citations
7.
Wang, Yang, Yanna Liu, Hao Liao, et al.. (2022). Serum HBV DNA plus RNA reflecting cccDNA level before and during NAs treatment in HBeAg positive CHB patients. International Journal of Medical Sciences. 19(5). 858–866. 17 indexed citations
8.
Liu, Yan, Rongjuan Chen, Wenhui Liu, et al.. (2021). Investigation of multidrug-resistance mutations of hepatitis B virus (HBV) in a large cohort of chronic HBV-infected patients with treatment of nucleoside/nucleotide analogs. Antiviral Research. 189. 105058–105058. 8 indexed citations
10.
Wang, Jun, Yan Liu, Hao Liao, et al.. (2020). The sK122R mutation of hepatitis B virus (HBV) is associated with occult HBV infection: Analysis of a large cohort of Chinese patients. Journal of Clinical Virology. 130. 104564–104564. 13 indexed citations
11.
Liao, Hao. (2019). Application value of serum HBV RNA in clinical management of chronic hepatitis B. SHILAP Revista de lepidopterología. 1 indexed citations
12.
Chang, Xiujuan, Yan Chen, Zujiang Yu, et al.. (2019). On-treatment monitoring of liver fibrosis with serum hepatitis B core-related antigen in chronic hepatitis B. World Journal of Gastroenterology. 25(32). 4764–4778. 16 indexed citations
13.
Yao, Mingjie, Hong You, Jianwen Wang, et al.. (2019). Serum GP73 combined AST and GGT reflects moderate to severe liver inflammation in chronic hepatitis B. Clinica Chimica Acta. 493. 92–97. 20 indexed citations
14.
Li, Fan, Xiaodong Li, Tao Yan, et al.. (2018). The preS deletion of hepatitis B virus (HBV) is associated with liver fibrosis progression in patients with chronic HBV infection. Hepatology International. 12(2). 107–117. 9 indexed citations
15.
Zhao, Li, Xiaodong Li, Yongqian Cheng, et al.. (2018). Hepatitis B virus rtA181T/sW172non-stop mutation may increase resistance fold to adefovir- and entecavir-resistant mutants compared to rtA181T/sW172* mutation. Antiviral Research. 154. 26–34. 12 indexed citations
16.
Liao, Hao, Yan Liu, Jianhong Chen, et al.. (2017). Characterization of hepatitis B virus (HBV) preS/S gene mutations in blood donors with occult HBV infection in the Baoji area of North China. Transfusion. 57(3pt2). 857–866. 25 indexed citations
17.
Liao, Hao, Xiaodong Li, Yan Liu, et al.. (2016). Intergenotype recombinant analysis of full‐length hepatitis B virus genomes from 516 Chinese patients with different illness categories. Journal of Medical Virology. 89(1). 139–145. 12 indexed citations
18.
Li, Xiaodong, Hao Liao, Yan Liu, et al.. (2016). Drug-Resistant and Genetic Evolutionary Analysis of Influenza Virus from Patients During the 2013 and 2014 Influenza Season in Beijing. Microbial Drug Resistance. 23(2). 253–260. 8 indexed citations
19.
20.
Li, Xiaodong, Yan Liu, Li Fan, et al.. (2016). PreS deletion profiles of hepatitis B virus (HBV) are associated with clinical presentations of chronic HBV infection. Journal of Clinical Virology. 82. 27–32. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026